Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
about
Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and ProgressionAt the interface of sensory and motor dysfunctions and Alzheimer's disease.The Eye As a Biomarker for Alzheimer's DiseaseOcular indicators of Alzheimer's: exploring disease in the retinaAlzheimer's disease: Unique markers for diagnosis & new treatment modalitiesLauriston S. Taylor Lecture on radiation protection and measurements: what makes particle radiation so effective?Early life nutrient restriction impairs blood-brain metabolic profile and neurobehavior predisposing to Alzheimer's disease with aging.Multiple Aggregation Pathways in Human γS-Crystallin and Its Aggregation-Prone G18V Variant.Down syndrome screening methods in Iranian pregnant women.The intellectual disability of trisomy 21: differences in gene expression in a case series of patients with lower and higher IQ.Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients.Alzheimer's disease diagnosis by detecting exogenous fluorescent signal of ligand bound to Beta amyloid in the lens of human eye: an exploratory studyRoles of the 15-kDa selenoprotein (Sep15) in redox homeostasis and cataract development revealed by the analysis of Sep 15 knockout miceFE65 and FE65L1 amyloid precursor protein-binding protein compound null mice display adult-onset cataract and muscle weaknessAmyloid-β(25-35) Modulates the Expression of GirK and KCNQ Channel Genes in the Hippocampus.Neuroinflammatory Cytokines-The Common Thread in Alzheimer's PathogenesisAge-related neurodegeneration and memory loss in down syndrome.Positron emission tomography and neuropathologic estimates of fibrillar amyloid-β in a patient with Down syndrome and Alzheimer disease.Ocular manifestations of Alzheimer's disease in animal models.A test of lens opacity as an indicator of preclinical Alzheimer Disease.δ-Catenin is genetically and biologically associated with cortical cataract and future Alzheimer-related structural and functional brain changes.An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome.Comparative proteomic analysis identifies age-dependent increases in the abundance of specific proteins after deletion of the small heat shock proteins αA- and αB-crystallin.Amyloid-β induces synaptic dysfunction through G protein-gated inwardly rectifying potassium channels in the fimbria-CA3 hippocampal synapse.Promise and challenge: the lens model as a biomarker for early diagnosis of Alzheimer's disease.Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatmentsAgeing in people with autistic spectrum disorder.Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways.GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease.Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis.One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina.Recent Perspectives on APP, Secretases, Endosomal Pathways and How they Influence Alzheimer's Related Pathological Changes in Down SyndromeVisual system manifestations of Alzheimer's disease.Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.Emerging ocular biomarkers of Alzheimer disease.Self-assembly of protein aggregates in ageing disorders: the lens and cataract model.Ferulic Acid Suppresses Amyloid β Production in the Human Lens Epithelial Cell Stimulated with Hydrogen PeroxideAminonaphthalene 2-cyanoacrylate (ANCA) probes fluorescently discriminate between amyloid-β and prion plaques in brainStrabismus, refractive errors and nystagmus in children and young adults with Down syndrome.Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.
P2860
Q26752621-4576994A-428E-4B71-A018-4318A2AE31F4Q27000410-5B253822-D888-4CA7-B95C-099266F8A44CQ28070142-6FE56399-DAC7-41EA-89BD-0E9A8FEA373AQ28078670-2F84A910-F1FE-4A17-9828-BCA9516BCF7BQ28085139-E5B9041E-E9A6-469D-82E4-A6CDD0457DE6Q28710510-80EF05F9-241E-479F-BC7B-61BDB4CA40F0Q30587668-AF6FB54E-16F8-459A-B685-1F3ACFEF850DQ33609571-D0FF96B2-CEEB-44F5-8FFF-D6CAB393082BQ34164343-8B012B4B-9492-4624-B38F-D549733A5A62Q34592175-24A925B1-CBB0-4392-8A35-67B6145BBCF8Q34743196-1DCB7403-EF97-452E-B4A5-5FAF177C4963Q34764050-1516868D-BC8F-4C22-8430-467AAD950E1BQ35312958-43356DE7-71C9-4A0C-9D35-3344E8805680Q35660090-F9F6E678-1637-439C-AE01-ECAFE8A53E36Q35719617-7427D905-C2EE-47B7-A188-50194ACAD840Q35815212-0E3508E0-3030-458A-8D72-3107A1C24135Q35867093-1FE008A1-FC24-4C92-AB18-76619E115463Q35940119-B90E2EC1-3250-4895-AE63-AADFBD4E31A2Q35993835-48DAF6C8-A285-4B06-82D5-D724AD45D43AQ36055299-BD06EFA4-B62D-4C7E-92B1-6B630AAC6C22Q36227117-10A7F2FE-1411-47F8-8B81-B1E00C395871Q36739111-95392358-ABB2-41A2-BC85-8F504042D518Q36949590-02FD9FD9-FB2E-4658-949C-B78005B2DD5CQ37043451-E6B364E6-D88C-433A-AE64-169B594A41E6Q37622009-E4BD12CE-52C1-491A-A0D3-A96F86A7C883Q37730984-C2E8FE8E-132D-4F0A-A45E-13FFF2C7FF84Q37871515-33A6BDD1-E040-497F-8EB6-E1F3AE055351Q38071004-02DC62E8-E1F0-491C-A6AA-4CCE1E545A95Q38225536-573AD41E-B9D8-4ED9-8C48-D36601D1F76CQ38719589-E4A5309F-E4B4-4F25-ADCC-2370DA9EFD01Q38873518-B3648C87-F6C0-41D0-A3DC-57B463EC3364Q38982671-0B3B1451-0D1D-4F6E-B803-24BE8DF23A79Q39013852-8AEAA7A0-7E4E-4E87-A831-3CE853841A28Q39091275-42F75ED4-FC82-47F6-8653-625C384AE74AQ39113804-165A41B2-FC0E-4AA1-A99C-83352536C937Q40183669-6F1B1D78-1AFC-402A-8A93-9DB8C5713F4AQ42177808-B5F41161-6A38-45ED-916F-735FBD49D8B1Q42406583-8A7C0C73-B624-42BD-8B81-1C621084254CQ44534263-8A2F4DB7-DC75-4FF9-B3CC-C77A164ACDBAQ46830566-BD7C3A8A-6071-485E-AF4D-76FA2A35E08C
P2860
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
@ast
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
@en
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
@en-gb
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
@nl
type
label
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
@ast
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
@en
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
@en-gb
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
@nl
altLabel
Alzheimer's Disease Amyloid-β Links Lens and Brain Pathology in Down Syndrome
@en
prefLabel
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
@ast
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
@en
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
@en-gb
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome
@en
P2093
Anca Mocofanescu
Jer R Kuszak
John I Clark
Joy G Ghosh
Maria Ericsson
Rebecca D Folkerth
Richard M Robb
Roberto Pineda
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0010659
P407
P50
P577
2010-01-01T00:00:00Z